Comparing Nukkleus (NASDAQ:NUKK) & Exponent (NASDAQ:EXPO)

Nukkleus (NASDAQ:NUKK) and Exponent (NASDAQ:EXPO) are both business services companies, but which is the superior business? We will contrast the two businesses based on the strength of their dividends, earnings, analyst recommendations, institutional ownership, risk, profitability and valuation.

Institutional & Insider Ownership

12.5% of Nukkleus shares are owned by institutional investors. Comparatively, 92.4% of Exponent shares are owned by institutional investors. 69.8% of Nukkleus shares are owned by insiders. Comparatively, 2.2% of Exponent shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Profitability

This table compares Nukkleus and Exponent’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Nukkleus	N/A	N/A	-4.47%
Exponent	18.69%	28.49%	16.58%

Volatility & Risk

Nukkleus has a beta of -0.32, meaning that its share price is 132% less volatile than the S&P 500. Comparatively, Exponent has a beta of 0.68, meaning that its share price is 32% less volatile than the S&P 500.

Analyst Recommendations

This is a summary of recent ratings and price targets for Nukkleus and Exponent, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Nukkleus	0	0	0	0	N/A
Exponent	0	1	1	0	2.50

Exponent has a consensus price target of $97.00, indicating a potential upside of 24.79%. Given Exponent’s higher possible upside, analysts plainly believe Exponent is more favorable than Nukkleus.

Valuation & Earnings

This table compares Nukkleus and Exponent’s revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Nukkleus	N/A	N/A	-$970,000.00	N/A	N/A
Exponent	$536.77 million	7.32	$100.34 million	$1.95	39.86

Exponent has higher revenue and earnings than Nukkleus.

Summary

Exponent beats Nukkleus on 9 of the 10 factors compared between the two stocks.

About Nukkleus

Nukkleus Inc., a financial technology company, focuses on providing software and technology solutions for retail foreign exchange trading industry worldwide. The company primarily offers software, technology, customer sales and marketing, and risk management technology hardware and software solutions. It also offers payment services from one fiat currency to another or to digital assets. The company was founded in 2013 and is headquartered in Jersey City, New Jersey. Nukkleus Inc. operates as a subsidiary of Global Elite Holdings Ltd.

About Exponent

Exponent, Inc., together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering. The Environmental and Health segment offers services in the areas of chemical regulation and food safety, ecological and biological sciences, environmental and earth sciences, and health sciences. The company offers approximately 90 technical disciplines to solve pressing and complicated challenges facing stakeholders. It serves clients in chemical, construction, consumer products, energy, food, beverage and nutrition, government, life sciences, insurance, manufacturing, technology, industrial equipment, transportation, and other sectors of the economy. The company was formerly known as The Failure Group, Inc. and changed its name to Exponent, Inc. in 1998. The company was founded in 1967 and is headquartered in Menlo Park, California.